Paradigm Health | AI Transformation Index
Paradigm Health is a structurally durable hospice care business in a heavily regulated, physically-delivered end market where AI disruption risk is minimal...

Overview
Paradigm Health is a hospice and palliative care provider operating six Indiana branches that delivers bedside end-of-life and serious-illness care — including clinical symptom management, care coordination, bereavement support, and enrichment programs — reimbursed primarily on a Medicare/Medicaid fee-for-service basis.
Executive Summary
Paradigm Health is a structurally durable hospice care business in a heavily regulated, physically-delivered end market where AI disruption risk is minimal — the core value proposition is human presence and clinical touch at the end of life, which no LLM or AI agent can replicate or disintermediate. The trade-off is that AI represents limited upside for this business: with most value created by boots-on-the-ground licensed clinicians rather than cognitive knowledge workers, the AI transformation opportunity is concentrated in administrative support functions and is incremental rather than transformational. For Cressey, this is a high-durability platform investment where the value creation thesis is organic growth, geographic expansion, and operational excellence — not AI-driven margin expansion — making AI transformation a modest operational tool rather than a strategic differentiator.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
54.8
Ciridae AI Score
Durability Rationale
Paradigm Health's durability rests on one of the strongest structural foundations available in healthcare services: the core paid outcome is irreducibly physical and human, delivered by licensed clinicians at the bedside of dying patients, and no AI capability on any foreseeable horizon substitutes that presence. The Medicare Hospice Benefit creates a regulatory architecture — mandatory licensure, mandated IDT composition, CoP surveys — that functions as a high wall against AI-native entry, and Paradigm's ACHC accreditation and referral network relationships add further incumbent advantages. The primary durability constraint is its single-state, regional footprint, which makes it more acquisition-dependent for scale than a structural weakness in the underlying business.
Opportunity Rationale
AI's reach into Paradigm Health's business is genuinely narrow: the production function is dominated by physical care delivery that AI cannot perform, and the cognitive workflows that AI could touch — documentation, scheduling, billing — are support functions rather than the core value-creation engine. There is no large manual cognitive workforce processing information at scale that AI could dramatically compress; Paradigm's 121 employees are primarily clinical field staff doing hands-on care. The most credible AI opportunity is documentation burden reduction (ambient clinical note-taking, automated care plan generation) and predictive referral analytics, both real but incremental improvements rather than step-change transformation.
Key Risks
If AI-enabled remote patient monitoring, predictive symptom management platforms, or AI care coordinators become CMS-approved substitutes for some visit-based care components, the physical-delivery moat could erode faster than anticipated — particularly for palliative (non-hospice) services where regulatory requirements are less prescriptive.
The opportunity assessment could be wrong if Paradigm's administrative and care coordination workflows are larger and more cognitive-labor-intensive than the data suggests — a 121-person organization may have more documentation, compliance, and scheduling overhead per patient than is visible externally, and AI tooling in those areas could compound meaningfully at scale as the company grows through M&A.
Company Overview
| Headquarters | Indianapolis, Indiana, United States |
| Products / Services | Hospice Care, Palliative Care, Bereavement Support, Enrichment Programs |
| Deal Partners |
PE / Ownership History
| Event | Details |
|---|---|
Cressey & Company invested in Paradigm Health May 12, 2025 | Cressey & Company, a healthcare-focused private equity firm, invested an undisclosed amount in Paradigm Health to support its growth and expansion in hospice and palliative care services. Havencrest Capital Management, which had previously invested in 2021, also participated. |
Executives
| Name | Background |
|---|---|
Andrew Worswick Chief Executive Officer (CEO) | Joined Paradigm Health in 2015 as a physical therapist, became COO in 2017, and CEO in 2023. Holds a Doctorate in Physical Therapy. Has two decades of healthcare experience with over 12 years in post-acute healthcare leadership. |
Ian Anderson Chief Financial Officer (CFO) | Previously on the investment team at Havencrest Capital Management, a healthcare private equity firm. Also worked at Capital Southwest on private credit and minority equity investments. |
Jenna Grimes Chief Compliance Officer (CCO) | Over 10 years with Paradigm Health, starting as an occupational therapist. Certified Hospice Operator through CHAP and Consultant for ACHC. |
Dawn Selke Chief Experience Officer (CXO) | Instrumental in the company's growth over the past decade. Oversees Brand and Marketing Strategy and Stakeholder Experience. |
Cressey & Company